FDA Import Refusal 1FX-7175607-6/10002/1 — Glaxosmithkline Pharmaceuticals
The FDA refused shipment 1FX-7175607-6/10002/1 from Glaxosmithkline Pharmaceuticals (India) on Jul 24, 2026. The refused product falls under Drugs and Biologics — BETAMETHASONE VALERATE (GLUCOCORTICOID). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Jul 24, 2026
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 64LDY08 BETAMETHASONE VALERATE (GLUCOCORTICOID)
- Charges
- 75